2022
DOI: 10.2147/tacg.s359479
|View full text |Cite
|
Sign up to set email alerts
|

ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy

Abstract: Pathogenic variants in the ABCD1 gene on the X chromosome may result in widely heterogenous phenotypes, including adrenomyeloneuropathy (AMN). Affected males typically present in their third or fourth decade of life with progressive lower limb weakness and spasticity, and may develop signs and symptoms of adrenal insufficiency and/or cerebral demyelination. Heterozygous females may be asymptomatic, but may develop a later-onset and more slowly progressive spastic paraparesis. In this review, we describe the cl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 112 publications
0
3
0
Order By: Relevance
“…Although both pathogenic variants reported here were predicted to cause a complete absence of the ABCD1 protein, the variant c.253delC in exon 1 led to the most severe cerebral X-ALD, while c.1275delA in exon 4 caused moderate AMN phenotype. The culprit seems to be multifactorial and besides toxicity of the accumulated VLCFA, modifier genes and environmental/epigenetic factors might contribute [ 21 , 22 , 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although both pathogenic variants reported here were predicted to cause a complete absence of the ABCD1 protein, the variant c.253delC in exon 1 led to the most severe cerebral X-ALD, while c.1275delA in exon 4 caused moderate AMN phenotype. The culprit seems to be multifactorial and besides toxicity of the accumulated VLCFA, modifier genes and environmental/epigenetic factors might contribute [ 21 , 22 , 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…Approximately 40% of individuals with AMN have some degree of brain involvement in neuroimaging. In approximately 20% of individuals with AMN, brain involvement eventually progresses and leads to cognitive and behavioral decline implying cerebral involvement ( 50 ). Clinical manifestations of cerebral involvement in individuals with AMN are identical to those observed with primary adult cerebral ALD, with the additional symptom of pre-existing myelopathy.…”
Section: Imaging Presentations: Difference From Childhood Leukodystro...mentioning
confidence: 99%
“…Clinical manifestations of cerebral involvement in individuals with AMN are identical to those observed with primary adult cerebral ALD, with the additional symptom of pre-existing myelopathy. Current guidelines on surveillance in individuals with pathogenic variants in ABCD1 is to perform MRI of the brain annually, as the development of cerebral changes even in late adulthood is known ( 50 ).…”
Section: Imaging Presentations: Difference From Childhood Leukodystro...mentioning
confidence: 99%